the CT bifurcation score as a novel tool for predicting intraprocedural side branch occlusion. EuroIntervention. 2019; 15(9):e788–e95.28 28 Dai T, Wang JR, Hu PF. Diagnostic performance of computed tomography angiography in the detection of coronary artery in‐stent restenosis: evidence from an updated meta‐analysis. Eur Radiol. 2018; 28(4):1373–82.
29 29 Van Mieghem CA, Cademartiri F, Mollet NR, et al. Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound. Circulation. 2006; 114(7):645–53.
30 30 Smith SC, Jr., Feldman TE, Hirshfeld JW, Jr., et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention‐Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006; 47(1):216–35.
31 31 Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr. 2010; 4(6):407.e1–33.
32 32 Opolski MP, Achenbach S. CT Angiography for Revascularization of CTO: Crossing the Borders of Diagnosis and Treatment. JACC Cardiovasc Imaging. 2015; 8(7):846–58.
33 33 Jungmann F, Emrich T, Mildenberger P, et al. Multidetector Computed Tomography Angiography (MD‐CTA) of Coronary Artery Bypass Grafts ‐ Update 2017. ROFO. 2018; 190(3):237–49.
34 34 Collet C, Onuma Y, Andreini D, et al. Coronary computed tomography angiography for heart team decision‐making in multivessel coronary artery disease. Eur Heart J. 2018; 39(41):3689–98.
35 35 Maffei E, Seitun S, Guaricci AI, Cademartiri F. Chest pain: coronary CT in the ER. Br J Radiol. 2016; 89(1061):20150954.
36 36 Hoffmann U, Bamberg F, Chae CU, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol. 2009; 53(18):1642–50.
37 37 Hamilton‐Craig C, Fifoot A, Hansen M, et al. Diagnostic performance and cost of CT angiography versus stress ECG‐‐a randomized prospective study of suspected acute coronary syndrome chest pain in the emergency department (CT‐COMPARE). Int J Cardiol. 2014; 177(3):867–73.
38 38 Litt HI, Gatsonis C, Snyder B, et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012; 366(15):1393–403.
39 39 Hoffmann U, Truong QA, Schoenfeld DA, et al. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med. 2012; 367(4):299–308.
40 40 Goldstein JA, Chinnaiyan KM, Abidov A, et al. The CT‐STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. J Am Coll Cardiol. 2011; 58(14):1414–22.
41 41 Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015; 372(14):1291–300.
42 42 Newby DE, Adamson PD, Berry C, et al. Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction. N Engl J Med. 2018; 379(10):924–33.
43 43 Moss AJ, Williams MC, Newby DE, Nicol ED. The Updated NICE Guidelines: Cardiac CT as the First‐Line Test for Coronary Artery Disease. Curr Cardiovasc Imaging Rep. 2017; 10(5):15.
44 44 Smulders MW, Kietselaer B, Wildberger JE, et al. Initial Imaging‐Guided Strategy Versus Routine Care in Patients With Non‐ST‐Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2019; 74(20):2466–77.
45 45 Nørgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol. 2014; 63(12):1145–55.
46 46 Hlatky MA, De Bruyne B, Pontone G, et al. Quality‐of‐Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM. J Am Coll Cardiol. 2015; 66(21):2315–23.
47 47 Zaid S, Ahmad H, Kaple R, et al. Novel Predictors of New Persistent Left Bundle Branch Block After SAPIEN 3 Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020; 13(9):1141–3.
48 48 Zaid S, Sengupta A, Okoli K, et al. Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020; 125(8):1222–9.
49 49 Sengupta A, Zaid S, Ahmad H, et al. Prosthesis–Patient Mismatch Between Transcatheter Heart Valves in TAVR Using a Computed Tomography–Derived Comparative Model. JACC: Cardiovascular Interventions. 2020; 13(6):790.
50 50 Blanke P, Weir‐McCall JR, Achenbach S, et al. Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): An Expert Consensus Document of the Society of Cardiovascular Computed Tomography. JACC: Cardiovascular Imaging. 2019; 12(1):1–24.
51 51 Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017; 14(10):e275–e444.
52 52 Krishnamurthy R, Cheong B, Muthupillai R. Tools for cardiovascular magnetic resonance imaging. Cardiovasc Diagn Ther. 2014; 4(2):104–25.
53 53 Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010; 55(23):2614–62.
54 54 Doherty JU, Kort S, Mehran R, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Nucl Cardiol. 2019; 26(4):1392–413.
55 55 McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium‐enhanced cardiovascular magnetic resonance. Circulation. 2003; 108(1):54–9.
56 56 Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 40(12):2156–64.
57 57 Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003; 41(9):1561–7.
58 58 Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic
